FMR LLC boosted its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 0.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 18,208,201 shares of the company's stock after purchasing an additional 39,158 shares during the period. FMR LLC owned about 15.17% of Privia Health Group worth $355,970,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PRVA. First Horizon Advisors Inc. boosted its holdings in shares of Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after buying an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock worth $47,000 after buying an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. purchased a new position in shares of Privia Health Group during the 4th quarter valued at $51,000. Neo Ivy Capital Management bought a new position in shares of Privia Health Group during the 3rd quarter worth $66,000. Finally, Quadrant Capital Group LLC increased its holdings in Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after acquiring an additional 511 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.
Privia Health Group Trading Down 0.1 %
Shares of Privia Health Group stock traded down $0.02 on Wednesday, hitting $24.17. 87,830 shares of the company traded hands, compared to its average volume of 781,139. The company has a market cap of $2.93 billion, a P/E ratio of 241.72, a P/E/G ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04. The firm's 50-day simple moving average is $23.80 and its 200 day simple moving average is $21.57.
Insider Buying and Selling at Privia Health Group
In other news, CFO David Mountcastle sold 5,630 shares of the firm's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at approximately $4,021,148.88. This trade represents a 3.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 14.20% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on PRVA shares. Piper Sandler increased their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday, February 28th. Robert W. Baird raised their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a report on Tuesday. Stephens reissued an "overweight" rating and set a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. JMP Securities set a $29.00 price target on Privia Health Group in a report on Friday, February 28th. Finally, Barclays boosted their price objective on Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a research note on Thursday, April 10th. One research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Privia Health Group presently has an average rating of "Buy" and a consensus price target of $27.00.
Read Our Latest Report on PRVA
Privia Health Group Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Articles

Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.